The largest database of trusted experimental protocols

2 protocols using medium 199 m199

1

Investigating ICAM-1 and NF-κB Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against human ICAM-1 and human CD68 were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Antibodies against human phosphorylated and total NF-κB p65 were obtained from Cell Signaling Technology (Beverly, MA). Recombinant human CD18 protein and antibody against β-actin were obtained from Abcam (Cambridge, MA). ICAM-1 neutralizing antibody and antibody against phosphorylated YAP were obtained from Thermo Fisher Scientific (Waltham, MA). Medium 199 (M199) was obtained from Lonza (Walkersville, MD). Roswell Park Memorial Institute medium (RPMI 1640) and phosphate-buffered saline (PBS) were obtained from GIBCO Laboratories (Grand Island, NY). Recombinant human matrilin-2 (endotoxin-free), β2-integrin neutralizing antibody, YAP inhibitor verteporfin (VP), antibody against total YAP, and ELISA kit for IL-6 were obtained from R and D Systems (Minneapolis, MN). NF-κB inhibitor Bay 11-7082 was obtained from Sigma-Aldrich (St. Louis, MO).
+ Open protocol
+ Expand
2

Antibody Validation for Inflammatory Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibody against ICAM-1 (sc-7891) was obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Antibodies against VCAM-1 (E1E8X) and MyD88 (D80F5) were obtained from Cell Signaling, Inc. (Beverly, MA). Antibody against TLR2 (NB100-56728) was obtained from Novus Biologicals, LLC (Centennial, CO). Antibodies against β-actin (ab49900) and GAPDH (ab9385) were obtained from Abcam (Cambridge, MA). Antibody against vimentin (ab137321) was obtained from Abcam (Cambridge, MA). Medium 199 (M199) was obtained from Lonza (Walkersville, MD). Roswell Park Memorial Institute medium (RPMI 1640) was obtained from GIBCO Laboratories (Grand Island, NY). Pam3CSK4 was obtained from InvivoGen (San Diego, CA). TLR2 inhibitor CU CPT 22 (4884) was obtained from Tocris Bioscience (Bristol, UK). Tumor necrosis factor-α (TNF-α) neutralizing antibody (MAB 610) was purchased from R&D System (Minneapolis, MN). Recombinant TNF-α, collagenase and other reagents were obtained from Sigma-Aldrich Chemical Co. (St Louis, MO).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!